Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients

Table 1

The clinical characteristics of 210 patients with conversion of tacrolimus from twice-daily to once-daily formulation.

Male	161 (76.7%)
Age (years)	52 (45–57) [4–69]*
Etiologies of liver transplantation
Hepatitis B	134 (63.8%)
Hepatitis C	36 (17.1%)
Hepatitis B + C	9 (4.3%)
Alcoholic	11 (5.2%)
Others	20 (9.5%)
HCC (+)	85 (40.5%)
Type of transplantation
Whole liver	53 (25.2%)
Split liver	24 (11.4%)
Living donor	133 (63.3%)
Tacrolimus dosage (mg/day) before conversion	3 (2–4)[1–9]*

∗Median (interquartile) [range].